The 9/11 event I am speaking at tonight is by donation–or for free if you cannot afford a donation. Sign up asap for a ticket

http://www.europarl.europa.eu/news/en/news-room/content/20140307IPR38203/html/US-NSA-stop-mass-surveillance-now-or-face-consequences-MEPs-say Parliament’s consent to the EU-US trade deal “could be endangered” if blanket mass surveillance by the US National Security Agency (NSA) does not stop, MEPs said on Wednesday, in a resolution wrapping up their six-month inquiry into US mass surveillance schemes. The text also calls on the EU to suspend its bank data deal…

From the Guardian: [UK Deputy Prime Minister Nick Clegg was] asked if there should be an inquiry into the role of British troops, [and] said: “I think anything that suggests that basic rules of war, conflict and engagement have been broken or that torture has been in any way condoned are extremely serious and need…

From Pro Publica: A senior Republican senator says it would take a powerful grassroots movement or startling new evidence to reopen the Justice Department’s investigation that branded a now-deceased Army researcher as the anthrax mailer who killed five people a decade ago. Iowa Sen. Charles Grassley, the ranking Republican on the Senate Judiciary Committee, and…

 https://www.aa.com.tr/en/africa/zimbabwe-oks-use-of-ivermectin-after-officials-deaths/2125442 Zimbabwe OKs use of Ivermectin after officials’ deaths ‘We have to be careful to protect patients as well as not to deny them effective treatment regimes,’ says Health Ministry John Cassim   |28.01.2021 HARARE, Zimbabwe Zimbabwe has approved the use and import of the anti-parasite drug Ivermectin to treat COVID-19 patients.  “In these difficult…

At the 12/2008 FDA-NIH meeting on how to study novel adjuvants, Novartis scientist (Novartis owns the MF59 adjuvant) Dr. Novicki made the following statement: “Carcinogenicity–we have done no testing for the carcinogenicity of MF59 adjuvant or any of our preventive vaccines. We haven’t done it and we don’t plan to.” (See page 391.) And if…